Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Clinical trial NCT01439373 · COMPLETED
Trial details
- NCT number
- NCT01439373
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-07
- Primary completion
- 2011-12-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.